Update on Positron Emission Tomography/Magnetic Resonance Imaging

Sabeghi, Paniz; Katal, Sanaz; Chen, Michelle; Taravat, Farzaneh; Werner, Thomas J.; Saboury, Babak; Gholamrezanezhad, Ali; Alavi, Abass

doi:10.1016/j.mric.2023.07.001

Cited by 3 publications

(4 citation statements)

References 132 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…PET and MRI can serve as complementary imaging modalities, each with their own strengths. Conventional MRI is known for its ability to provide high-resolution structural images of the brain, offering exceptional tissue contrast [11]. As such, it is an invaluable imaging modality for many non-traumatic anatomical neurological conditions, including epilepsy and tumors [12].…”

Section: Pet and Pet/mr In Neuro-oncologymentioning

confidence: 99%

“…When employed in tandem, PET/MRI offers a number of compelling advantages, including enhanced soft tissue contrast and a reduction in ionizing radiation exposure [11,12]. Head movement during PET scanning can disrupt proper attenuation correction or result in incorrect alignment of PET information with MR images.…”

Section: Pet and Pet/mr In Neuro-oncologymentioning

confidence: 99%

“…Head movement during PET scanning can disrupt proper attenuation correction or result in incorrect alignment of PET information with MR images. To address this, motion tracking based on MR imaging can be employed to reposition the PET data accurately [11,18]. The decrease in radiation is particularly beneficial for the pediatric population, where CNS cancer is a leading cause of death.…”

Section: Pet and Pet/mr In Neuro-oncologymentioning

confidence: 99%

See 2 more Smart Citations

Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain Tumors

Sabeghi,

Zarand,

Zargham

et al. 2024

Cancers

Self Cite

View full text Add to dashboard Cite

This study delineates the pivotal role of imaging within the field of neurology, emphasizing its significance in the diagnosis, prognostication, and evaluation of treatment responses for central nervous system (CNS) tumors. A comprehensive understanding of both the capabilities and limitations inherent in emerging imaging technologies is imperative for delivering a heightened level of personalized care to individuals with neuro-oncological conditions. Ongoing research in neuro-oncological imaging endeavors to rectify some limitations of radiological modalities, aiming to augment accuracy and efficacy in the management of brain tumors. This review is dedicated to the comparison and critical examination of the latest advancements in diverse imaging modalities employed in neuro-oncology. The objective is to investigate their respective impacts on diagnosis, cancer staging, prognosis, and post-treatment monitoring. By providing a comprehensive analysis of these modalities, this review aims to contribute to the collective knowledge in the field, fostering an informed approach to neuro-oncological care. In conclusion, the outlook for neuro-oncological imaging appears promising, and sustained exploration in this domain is anticipated to yield further breakthroughs, ultimately enhancing outcomes for individuals grappling with CNS tumors.

show abstract

Section: Pet and Pet/mr In Neuro-oncologymentioning

confidence: 99%

Section: Pet and Pet/mr In Neuro-oncologymentioning

confidence: 99%

Section: Pet and Pet/mr In Neuro-oncologymentioning

confidence: 99%

See 1 more Smart Citation

Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain Tumors

Sabeghi,

Zarand,

Zargham

et al. 2024

Cancers

Self Cite

View full text Add to dashboard Cite

show abstract

“…PET/MRI is an advanced integrated imaging method making its way into clinical practice [ 87 ]. FDG PET/MRI combines the metabolic information of FDG PET with the high-resolution soft-tissue characteristics offered by MRI within a single examination.…”

Section: Introductionmentioning

confidence: 99%

PET Molecular Imaging in Breast Cancer: Current Applications and Future Perspectives

Katal,

McKay,

Taubman

2024

JCM

Self Cite

View full text Add to dashboard Cite

Positron emission tomography (PET) plays a crucial role in breast cancer management. This review addresses the role of PET imaging in breast cancer care. We focus primarily on the utility of 18F-fluorodeoxyglucose (FDG) PET in staging, recurrence detection, and treatment response evaluation. Furthermore, we delve into the growing interest in precision therapy and the development of novel radiopharmaceuticals targeting tumor biology. This includes discussing the potential of PET/MRI and artificial intelligence in breast cancer imaging, offering insights into improved diagnostic accuracy and personalized treatment approaches.

show abstract

Deep radiomics-based prognostic prediction of oral cancer using optical coherence tomography

Yuan,

Rao,

Liu

et al. 2024

BMC Oral Health

View full text Add to dashboard Cite

Update on Positron Emission Tomography/Magnetic Resonance Imaging

Cited by 3 publications

References 132 publications

Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain Tumors

Advances in Neuro-Oncological Imaging: An Update on Diagnostic Approach to Brain Tumors

PET Molecular Imaging in Breast Cancer: Current Applications and Future Perspectives

Deep radiomics-based prognostic prediction of oral cancer using optical coherence tomography

Contact Info

Product

Resources

About